NCT07779993

Brief Summary

This is a study at sohag university hospital aim to demonstrate if children with celiac disease have more sensitivity of their myocardium to arrhythmia compared to healthy children.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for all trials

Timeline
10mo left

Started Aug 2026

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress9%
Aug 2026Jul 2027

Study Start

First participant enrolled

August 1, 2026

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

August 14, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 21, 2026

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

August 21, 2026

Status Verified

July 1, 2026

Enrollment Period

10 months

First QC Date

August 14, 2026

Last Update Submit

August 18, 2026

Conditions

Keywords

Celiac DiseaseTp-e Interval and QT dispersion

Outcome Measures

Primary Outcomes (1)

  • Assessment of Tp-e Interval

    Assessment of Tp-e Interval in children diagnosed with celiac disease and compare it with healthy children

    1 year

Secondary Outcomes (1)

  • Assessment of QT dispersion

    1 year

Study Arms (1)

children with celiac disease

children from birth to 18 years old diagnosed with celiac disease visit sohag university hospital

Other: No intervention (observational study)

Interventions

the study don't need intervention.

children with celiac disease

Eligibility Criteria

Age0 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All children who confirmed diagnosed as celiac disease who visit sohag University Hospital at time of study under 18 years old and don't have any associated disease cross matched with same number of healthy children at the same age and not have any other problems at the duration of study.

You may qualify if:

  • All children who confirmed diagnosed as celiac disease who visit sohag University Hospital

You may not qualify if:

  • cardiac disease.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University Hospital

Sohag, Egypt

Location

Related Links

MeSH Terms

Conditions

Celiac Disease

Interventions

Observation

Condition Hierarchy (Ancestors)

Malabsorption SyndromesIntestinal DiseasesGastrointestinal DiseasesDigestive System DiseasesMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Central Study Contacts

Merna Fayez Shenouda

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
pediatric resident- Fever Hospital Sohag

Study Record Dates

First Submitted

August 14, 2026

First Posted

August 21, 2026

Study Start

August 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

August 21, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

individuals participant data will not be shared due to privacy protection policies at Sohag university Hospital

Locations